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Abstract
Background:  Although health-related quality of life (HRQOL) is a potential independent
predictor of mortality, nephrologists have shown little interest in HRQOL with respect to
mortality in chronic kidney disease (CKD). The aim of this article is to evaluate the impact of
HRQOL on mortality in the elderly, who are likely to develop or already have CKD.
Methods: Among 1,000 randomly sampled participants aged more than 65 years (sourced from
the Korean Longitudinal Study on Health and Ageing), 944 subjects were evaluated for HRQOL.
HRQOL was assessed using a 36-item Short-Form health survey (SF36). A cumulative survival rate
was calculated according to tertiles of SF36 scores and classified by the presence of CKD
(estimated GFR <60 ml/min/1.73 m2).
Results:  Among 944 subjects, 46.6% had CKD. CKD patients had lower total and physical
component scores compared with subjects without CKD. The 3-year cumulative survival rate was
90.0% (non-CKD vs. CKD: 92.6% vs. 87.4%, P = 0.005 by log rank test). After adjusting for multiple
variables, a reduced SF36 score (physical and mental components) was a strong predictor of all-
cause mortality. Physical components were consistently able to predict mortality after CKD
classification, but mental components were statistically significant only in the CKD group.
Conclusion: In addition to traditional risk factors of mortality, nephrologists should be aware of
HRQOL as a predictor of mortality and should make efforts to improve HRQOL in CKD patients.
Background
"The aging society" is a familiar term as elderly individuals
(aged 65 years and older) make up an increasing propor-
tion of the global population [1]. In line with global
trends, the proportion of the elderly in Korea is increasing
(8.3% in 2003) and is expected to reach 15% in 2019 [2].
This increase may lead to age-associated increases in
chronic diseases. Chronic kidney disease (CKD) has been
recognized as one of a number of chronic diseases prima-
rily affecting the elderly. Worldwide, the prevalence of
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CKD in the elderly has increased to nearly half of the pop-
ulation aged 70 years and older [3], and the incidence
among the elderly in Korea is similar [4]. Therefore, the
problems associated with CKD need to be appropriately
managed to reduce the burden of CKD in the aging soci-
ety.
The ability to predict future morbidity and mortality is a
key to reduce the burden of CKD. To this end, monitoring
a patient's functional and subjective status of well-being,
collectively known as health-related quality of life
(HRQOL), is of particular importance in CKD patients [4-
7]. Traditional risk factors (e.g., atherosclerosis, smoking,
and diabetes mellitus) for mortality had been considered
important in the elderly with or without CKD [8,9]; how-
ever, it is currently thought that traditional risk factors do
not account for all reported mortality [10]. Recently,
HRQOL, comprising physical, mental, and social health,
is recognized as an important predictor of mortality in
elderly individuals or patients with end-stage renal disease
[5,7,11,12]. However, nephrologists have shown little
interest in the role that HRQOL plays in mortality in CKD
patients [13].
The 36-item Short-Form health survey (SF36) has been
validated as a QOL assessment tool for a wide variety of
patients, including CKD patients [14-16]. Here, we evalu-
ate HRQOL using the SF36 and assess the impact of
HRQOL on mortality in the elderly, who are likely to
develop or already have CKD.
Methods
Study Participants
The present study was designed as a population-based,
prospective cohort study of health, aging, and common
geriatric diseases in a population aged ≥ 65 years in Seong-
nam-si, a satellite city of Seoul, Korea. The study design
was described in detail elsewhere as an element of the
Korean Longitudinal Study on Health and Aging (KLo-
SHA) [17]. The baseline phase of KLoSHA began in Sep-
tember 2005. The KLoSHA includes two cohorts, one
selected from the total population of Seongnam-si
(931,019 individuals) and a 6.6% sample of the popula-
tion aged ≥ 65 years. For the elderly sample (Sample-RE),
a simple random sample (1,118 individuals, 1.81%) was
selected from a list of 61,730 residents aged ≥ 65 years as
of August 1, 2005. The sampled subjects were invited to
participate in the study by letter and telephone. Of the
1,118 candidates, 698 agreed to participate in the baseline
KLoSHA study. For the "oldest old age" sample (Sample-
OO), all individuals aged ≥ 85 years in Seongnam-si
(3,136 persons) were contacted by letter and telephone,
and 302 agreed to participate in the KLoSHA. We enrolled
the Sample-OO in addition to the Sample-RE. All partici-
pants were Korean. From a random sample of 1,000 par-
ticipants, we evaluated 944 who had examined the SF36.
All assessments were performed at the Seoul National
University Bundang Hospital in Gyeonggi-do, Korea. An
independent ethics committee at each participating insti-
tution (SNUBH) approved the study protocol (B-0508/
023-003). The study was conducted in accordance with
the Declaration of Helsinki.
Measurements and Definitions
The investigated clinical parameters included age, sex,
ever-drinking, ever-smoking, and a history of hyperten-
sion, diabetes mellitus, coronary heart disease (CHD), or
cerebrovascular accident (CVA). Systolic blood pressure
(SBP) and diastolic blood pressure (DBP) were measured
after participants had rested for at least 3 minutes. Numer-
ous laboratory measurements were obtained. Serum
measurements included hemoglobin, glucose, total pro-
tein, albumin, total cholesterol, triglyceride, high-density
lipoprotein (HDL) cholesterol, and creatinine (Cr) levels.
Urine measurements included a dipstick test for albumin
and measurement of red blood cell (RBC) counts per
high-power field by light microscopy. Glomerular filtra-
tion rate (GFR) was calculated for 932 participants using
the Modification of Diet in Renal Disease (MDRD) Study
equation [18].
Patients with one of the following were classed as hyper-
tensive: SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, or use of
antihypertensive medication, irrespective of BP. Diabetes
mellitus was defined as a fasting glucose level ≥ 126 mg/
dL or the use of hypoglycemic agents. CHD was defined as
self-reported history of angina pectoris, acute myocardial
infarction, percutaneous coronary intervention, or coro-
nary artery bypass operation. Proteinuria was defined as
albumin ≥ 1+ and hematuria as an RBC count >5 per high-
power field. CKD was defined as an estimated GFR <60
ml/min/1.73 m2 [19].
The HRQOL of subjects was assessed using the Korean
version of the SF36 [14,20]. It consists of 36 questions, 35
of which are included on eight multi-item scales: Physical
Functioning, Role--Physical, Bodily Pain, General Health,
Vitality, Social Functioning, Role--Emotional, and Mental
Health. The SF36 assesses physical and mental health
components. All-cause mortality data were obtained from
the Ministry of Public Administration and Security's
national database in June 2009.
Statistical analysis
All analyses were performed using SPSS software (SPSS
version 16.0, Chicago, IL, USA). Data were presented as
mean/standard deviations (SD) for continuous variables
and as proportions for categorical variables. Demographic
and clinical data were described and compared between
CKD and non-CKD groups. Differences were analyzedBMC Nephrology 2009, 10:39 http://www.biomedcentral.com/1471-2369/10/39
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using the χ2 test for categorical variables and the Student's
t  test for non-categorical variables. All subjects were
divided into three groups according to tertiles of SF36
scores. The Kaplan-Meier method and the log rank test
were used to assess and compare cumulative mortality
rates between non-CKD and CKD groups. The unadjusted
hazard ratios for all-cause mortality were calculated by the
Cox proportional hazard model (model 1), and adjust-
ments were made (model 2). Variables included for
adjustments were age, gender, and others that had P val-
ues of less than 0.05 in univariate analyses. The hazard
ratio for all-cause mortality was calculated after classifying
subjects according to the presence of CKD. A P value of
less than 0.05 was considered significant.
Results
Baseline characteristics of participants
Table 1 shows the patient baseline characteristics. Of the
944 participants, 424 (44.9%) were male and 520
(55.1%) were female. The mean age was 76 years (range,
65-98 years). The proportions with hypertension and dia-
betes were 71.1% and 20.9%, respectively. The mean cre-
atinine level was 1.12 mg/dL and the mean GFR was 61.1
ml/min/1.73 m2. Among the participants, 46.6% had a
GFR of less than 60 ml/min/1.73 m2; 8 (0.9%) had a GFR
of 15-30 ml/min/1.73 m2, and 2 (0.2%) had a GFR of less
than 15 ml/min/1.73 m2. The physical component score
was significantly lower in CKD patients than in non-CKD
subjects.
Table 1: Demographics of participants responding to the baseline Short Form with 36 questions
CKD (-)
(n = 488)
CKD (+)
(n = 444)
Total subjects
(n = 944)
Age‡ 74.8/8.2 77.4/8.9 76.0/8.6
Male gender (%)‡ 52.9 36.5 45.1
Hypertension (%) * 68.0 74.4 71.1
Diabetes mellitus (%) 20.9 20.5 20.9
CHD (%)† 4.7 10.6 7.6
CVA (%) 9.2 11.0 10.1
Ever-drinking (%)‡ 45.5 32.4 39.2
Ever-smoking (%) * 43.1 35.7 39.6
SBP (mmHg) 132.6/17.8 132.2/18.3 132.5/18.1
DBP (mmHg) 82.8/10.2 82.5/11.0 82.7/10.6
Serum findings
Hemoglobin (g/dL)‡ 13.9/1.6 13.6/1.4 13.7/1.5
Glucose (mg/dL)† 111.0/28.0 106.4/20.9 108.9/25.1
Total protein (g/dL) 7.4/0.47 7.5/0.46 7.5/0.46
Albumin (g/dL) 4.09/0.27 4.09/0.22 4.09/0.24
Total cholesterol (mg/dL) * 199.5/37.5 205.7/37.6 202.7/37.9
Triglyceride (mg/dL) 131.1/88.8 137.8/72.9 135.0/82.1
HDL cholesterol (mg/dL) 60.8/16.0 59.5/14.8 60.2/15.4
Creatinine (mg/dL)‡ 0.98/0.15 1.27/0.41 1.12/0.34
eGFR (ml/min/1.73 m2)‡ 70.2/8.7 51.0/8.1 61.1/12.8
Proteinuria (%) 7.4 9.4 8.4
Hematuria (%) 9.9 11.3 10.8
SF36 score
Physical functioning† 56.9/27.89 50.6/29.60 53.9/28.88
Role---physical† 71.1/28.46 65.3/32.70 68.4/30.67
Bodily pain 63.1/28.11 59.3/31.64 61.3/29.89
General health 43.8/21.85 42.7/22.05 43.3/21.94
Vitality 52.3/20.56 50.6/21.87 51.5/21.20
Social functioning 79.5/23.55 76.4/26.80 78.0/25.18
Role---emotional 81.4/26.00 78.3/29.36 79.9/27.68
Mental health 68.6/19.52 67.6/20.84 68.1/20.15
PCS† 55.8/13.3 53.1/14.6 54.5/14.0
MCS 52.2/10.1 51.1/11.0 51.7/10.5
Median follow-up (interquartile, months) 39 (35--42) 39 (35--41) 39 (35--42)
GFR was not estimated in twelve subjects.
P < 0.05, † P < 0.01, ‡ P < 0.001
Abbreviations: CKD: chronic kidney disease; CHD: coronary heart disease; CVA: cerebrovascular accident; SBP: systolic blood pressure; DBP: 
diastolic blood pressure; HDL: high-density lipoprotein; eGFR: estimated glomerular filtration rate; SF36: 36-item Short-Form health survey; PCS: 
physical component summary score; MCS: mental component summary score.BMC Nephrology 2009, 10:39 http://www.biomedcentral.com/1471-2369/10/39
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During the 3-year follow-up period (0-45 months), 104
subjects (11.0%) died. Among the clinical and laboratory
parameters in Table 1 (excluding the SF36 scores), the
mortality rate was associated with age (52.3% older vs.
47.7% younger by a median age of 73 years: OR 5.97
(3.50-10.20),  P  < 0.001), ever-smoking (+39.6% vs. -
60.4%: OR 1.60 (1.08-2.35), P  = 0.018), proteinuria
(+8.4% vs. -91.6%: OR 2.08 (1.20-3.61), P  = 0.009),
serum levels of hemoglobin (1 g/dL increase: OR 0.83
(0.74-0.94), P = 0.002), total protein (1 g/dL increase: OR
0.50 (0.33-0.75), P = 0.001), albumin (1 g/dL increase:
OR 0.17 (0.10-0.27), P < 0.001), total cholesterol (1 mg/
dL increase: OR 0.99 (0.99-1.00), P = 0.004), HDL choles-
terol (1 mg/dL increase: OR 0.98 (0.97-1.00), P = 0.007),
and estimated GFR (CKD vs. non-CKD: OR 1.74 (1.17-
2.58), P = 0.006). These variables were used for adjust-
ments in multivariate analyses. The 3-year cumulative sur-
vival rate was 90.0% (non-CKD group vs. CKD group:
92.6% vs. 87.4%, P = 0.005 by the log rank test).
Influence of health-related quality of life on all-cause 
mortality
Each 10-unit increase on the eight scales was associated
with decreased all-cause mortality in study participants
after adjustment for multiple variables (Table 2). Univar-
iate analysis showed that groups with high scores of SF36
components (except general health) had greater survival
rates than groups with low scores. This trend remained
consistent after adjustment (model 2).
Upper tertiles in physical and mental component scores
were more highly correlated with improved survival rate
than lower tertiles. Using 10-unit increases in physical
and mental components, the increase in each score was
associated with reduced mortality: the physical compo-
nent score had an adjusted OR of 0.71 ((0.61-0.84), P <
0.001); the mental component score had an adjusted OR
of 0.65 ((0.54-0.78), P < 0.001).
We divided subjects into two groups on the basis of pres-
ence of CKD. Figure 1 and Figure 2 show the Kaplan-Meier
curve according to tertiles of SF36 scores and the presence
of CKD. Cumulative survival rates according to physical
and mental component scores were further separated by
the presence of CKD (P < 0.001 in Figure 1 and Figure 2
by the log rank test). By multivariate analysis (Table 3),
the physical component score was associated with all-
cause mortality, irrespective of CKD. The mental compo-
nent score was significantly correlated with all-cause mor-
tality in the CKD group; however, the correlation was only
marginally significant in the non-CKD group.
Discussion
Clinicians focus on newer risk factors (e.g., inflammation,
oxidative stress, and epigenetic change) as well as tradi-
tional risk factors (e.g., atherosclerosis, smoking, and dia-
betes mellitus) when assessing mortality risk in patients
with CKD [21]. It is essential to evaluate non-typical risk
factors because the aging society is more heavily con-
Table 2: Hazard ratios for all-cause mortality according to SF36 scores (n = 944)
Model 1a Model 2b
SF36 survey HR (95% CI) P value HR (95% CI) P value
10-unit increase in SF36 components
Physical functioning 0.78 (0.72--0.83) <0.001 0.81 (0.75--0.89) <0.001
Role---physical 0.85 (0.81--0.90) <0.001 0.90 (0.85--0.96) 0.001
Bodily pain 0.90 (0.85--0.96) 0.002 0.92 (0.86--0.99) 0.020
General health 0.93 (0.85--1.02) 0.123 0.90 (0.82--1.00) 0.052
Vitality 0.85 (0.77--0.93) <0.001 0.88 (0.79--0.98) 0.018
Social functioning 0.83 (0.78--0.90) <0.001 0.87 (0.81--0.93) <0.001
Role---emotional 0.84 (0.80--0.89) <0.001 0.88 (0.83--0.93) <0.001
Mental health 0.85 (0.78--0.93) 0.001 0.83 (0.75--0.91) <0.001
Physical component summary score
Tertile 1 (<49.4) 1 (Reference) 1 (Reference)
Tertile 2 (49.4--61.7) 0.46 (0.30--0.72) 0.001 0.54 (0.33--0.87) 0.011
Tertile 3 (>61.7) 0.25 (0.14--0.43) <0.001 0.35 (0.19--0.64) 0.001
Mental component summary score
Tertile 1 (<49.0) 1 (Reference) 1 (Reference)
Tertile 2 (49.0--57.0) 0.68 (0.44--1.05) 0.082 0.63 (0.40--1.01) 0.055
Tertile 3 (>57.0) 0.36 (0.21--0.61) <0.001 0.39 (0.22--0.70) 0.001
a Unadjusted model.
bModel adjusted for age, gender, ever-smoking, proteinuria, serum levels of hemoglobin, total protein, albumin, cholesterol, HDL cholesterol, and 
estimated GFR.
Abbreviations: SF36: 36-item Short-Form health survey; HR: hazard ratio; CI: confidence interval.BMC Nephrology 2009, 10:39 http://www.biomedcentral.com/1471-2369/10/39
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fronted with various non-traditional co-morbidities. In
the present study, we evaluated the relationship between
HRQOL, as measured by the SF36, and all-cause mortality
in an elderly population with or without CKD. Both phys-
ical and mental components, including each health com-
ponent, affected all-cause mortality in elderly subjects.
This trend was consistent for individuals with CKD. To the
best of our knowledge, although HRQOL is known to be
related to mortality in patients with end-stage renal dis-
ease, no report has been published on the correlation
between HRQOL and mortality in patients with CKD.
This issue should be kept in mind by nephrologists who
may otherwise not be interested in the QOL of CKD
patients.
The SF36 is an approved test that is applicable to healthy
elderly individuals as well as CKD patients [14-16]. Han
et al. also used the SF36 for assessing HRQOL in elderly
Koreans (n = 219, aged 73.7 years) [22]. The SF36 scores
for each component were similar between Han's cohort
and our study cohort, but scores of social functioning, role
emotional, and mental health were higher in our cohort.
Recently, Mujais et al. reported HRQOL in CKD patients
using the Kidney Disease Quality of Life (KDQOL) ques-
tionnaire, which combines the generic SF36 instrument
with a kidney disease-specific instrument [23]. In their
study, the mean physical and mental component scores
for stage 3 CKD patients were 40 and 51, respectively.
Although comparison between two cohorts is impossible
Table 3: Stratified analysis of all-cause mortality by the presence of chronic kidney disease
CKD (-) (n = 488) CKD (+) (n = 444)
SF36 survey HR (95% CI) P value HR (95% CI) P value
Physical component summary score
Tertile 1 (<49.4) 1 (Reference) 1 (Reference)
Tertile 2 (49.4--61.7) 0.44 (0.21--0.92) 0.029 0.54 (0.28--1.05) 0.068
Tertile 3 (>61.7) 0.23 (0.09--0.60) 0.003 0.44 (0.20--0.98) 0.045
Mental component summary score
Tertile 1 (<49.0) 1 (Reference) 1 (Reference)
Tertile 2 (49.0--57.0) 0.67 (0.33--1.37) 0.273 0.51 (0.27--0.99) 0.041
Tertile 3 (>57.0) 0.41 (0.16--1.05) 0.051 0.35 (0.17--0.74) 0.006
Model adjusted for age, gender, ever-smoking, proteinuria, serum levels of hemoglobin, total protein, albumin, cholesterol, HDL cholesterol, and 
estimated GFR.
Abbreviations: CKD, chronic kidney disease; SF36, 36-item Short-Form health survey; HR, hazard ratio; CI, confidence interval.
Survival curves classified by the presence of chronic kidney  disease: physical component score Figure 1
Survival curves classified by the presence of chronic 
kidney disease: physical component score. The Kaplan-
Meier curve is assessed in participants according to the phys-
ical component score. Tertiles in physical component score: 
T1, <49.4; T2, 49.4--61.7; T3, >61.7.
Survival curves classified by the presence of chronic kidney  disease: mental component score Figure 2
Survival curves classified by the presence of chronic 
kidney disease: mental component score. The Kaplan-
Meier curve is assessed in participants according to the men-
tal component score. Tertiles in mental component score: 
T1, <49.0; T2, 49.0--57.0; T3, >57.0.BMC Nephrology 2009, 10:39 http://www.biomedcentral.com/1471-2369/10/39
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because of different baseline characteristics (low propor-
tion of diabetes mellitus, high serum levels of hemo-
globin and albumin in our cohort), we assumed that SF36
scores from the randomly sampled design of our cohort
could be representative of HRQOL among the elderly in
Seongnam-si.
The association between negative self-assessment of
health status and mortality in the elderly has been noted
for more than 30 years, since Maddox's report [24]. Ber-
nard et al. evaluated the relationship between self-assess-
ment of health status and the subsequent risk of death
among the elderly during a 2.5-year period [12]. When
3,485 elderly subjects were asked, "How would you rate
your health at the present time?", the group with an
answer of "poor" (the most negative of five possible
responses) had an adjusted hazard ratio of 5.5 (4.0-7.5)
for mortality compared with those who answered "excel-
lent" (the most positive of five possible responses). Sev-
eral hypotheses have been proposed to explain the
correlation between HRQOL and clinical outcome. For
example, a negative self-evaluation of health could stimu-
late a psychoneuroimmunologic response, reflect the eld-
erly person's accurate self-detection of preclinical changes
in body function, or lead to a delay in taking health-pro-
tective and maintenance actions [12,25]. In some reports,
HRQOL has been shown to be related to nutritional fac-
tors, such as cholesterol and hemoglobin levels [4,5].
However, it is not fully understood why subjective assess-
ment of health status is strongly correlated with objective
clinical outcome after adjustment for chemical markers.
Interestingly, the mental component score did not differ
between two groups that were divided by an eGFR of 60
ml/min/1.73 m2. However, the mental component score
in the CKD group was a greater predictor of mortality than
in the non-CKD group. The reason for the weak correla-
tion between the mental component score and mortality
in the elderly without CKD is not clear. It might be
because sample number was modest after classification or
that elderly individuals without CKD were more strongly
affected by the physical component than by the mental
component. On the other hand, some studies have
reported that a depressed mental state is common and
clearly correlated with mortality in patients with end-stage
renal disease, consistent with our results [26,27].
The importance of HRQOL in patients with end-stage
renal disease is well known. DeOreo et al. examined the
SF36 score in 1,000 patients who underwent hemodialy-
sis [28]; the median values of the physical and mental
component scores were 37 and 47, respectively. It was
revealed that a low SF36 score, particularly a low physical
component score, was associated with increased hospital-
ization and mortality rates. Kalantar-Zadeh et al. also
measured SF36 scores in 65 end-stage renal disease
patients and found a correlation with hospitalization and
mortality; the mental component score and total score
had the strongest correlations [5]. Furthermore, these
researchers revealed that serum albumin and hemoglobin
levels were associated with SF36 scores. However, few
studies have investigated CKD patients with reduced renal
function (GFR less than 60 ml/min/1.73 m2). The present
study showed that elderly CKD patients had lower
HRQOL scores than subjects without CKD; this reduced
HRQOL score was strongly associated with increased all-
cause mortality after adjustment for traditional risk factors
and chemical markers. Furthermore, as shown in Figure 1
and Figure 2, HRQOL further separated the mortality rate
according to the presence of CKD. In this regard, we
should treat HRQOL and CKD equally.
Although our results are informative, our study is not
without limitations. First, because all participants in our
cohort were elderly Asian individuals, our results may not
be applicable to other ethnic groups or adults aged <65
years with CKD. Indeed, Lopes et al. have reported differ-
ences in HRQOL among various ethnic groups undergo-
ing hemodialysis [29]. Second, the MDRD equation has
not yet been investigated in the Korean population and
may not be appropriate for the elderly population. Third,
HRQOL was measured only once at the start of the present
prospective research; therefore, our data do not show
changes during the follow-up period. Fourth, HRQOL was
higher than expected (mean value: 54.5 in the physical
component; 51.7 in the mental component). However,
the purpose of our study was not to evaluate the cut-off
point of the SF36 score. Rather, we sought to understand
an independent correlation between HRQOL and mortal-
ity in CKD patients.
Conclusion
The present study demonstrated that HRQOL was a strong
predictor of all-cause mortality in an elderly Asian popu-
lation, including subjects with CKD. Although the present
study does not reveal the mechanism by which the subjec-
tive HRQOL is correlated with the objective outcome of
mortality, it would be reasonable to try to improve
HRQOL in the elderly and CKD patients to reduce mortal-
ity. This is a responsibility of clinicians that will be more
important in the aging society as the prevalence of CKD
increases. Further studies are needed to ascertain how
interventions to increase HRQOL can reduce mortality
rates in CKD patients.
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